J&J's MedTech Segment Slowing Down: Will its Sales Recover in 2025?
Johnson & Johnson JNJ is one of the few large drug and medical device companies with a presence in both the pharmaceuticals as well as medical devices segments. J&J's medical devices segment, called MedTech, offers products in the orthopedics, surgery, cardiovascular and vision markets. The MedTech segment accounts for around 36% of J&J's total revenues.
Sales in the MedTech segment rose 4.1% on an operational basis in the first quarter of 2025, driven by new product uptake and commercial execution, and contributions from the recent acquisitions of Shockwave and Abiomed.
However, sales in J&J's MedTech business continue to face headwinds in the Asia Pacific, particularly in China. Sales in China are being hurt by the impact of the volume-based procurement (VBP) program and the anticorruption campaign. VBP is a government-driven cost-containment effort in China.
In the MedTech segment, recent acquisitions of Shockwave and Abiomed, as well as continued uptake of its new products, are likely to drive growth in 2025. However, J&J does not expect any improvement in its business in the Asia Pacific region, specifically in China, in 2025. Competitive pressure is also hurting sales growth in some MedTech businesses, such as PFA ablation catheters in U.S. electrophysiology. JNJ expects continued impacts from VBP issues in China in 2025 as VBP expands across provinces and products.
Nonetheless, sales are expected to be higher in the second half of 2025 than in the first half as the business moves past tougher first-quarter comps and new products gain momentum throughout 2025. However, tariff-related costs are expected to hurt profits in the MedTech segment
J&J's Key Competitors in the Medical Devices Market
J&J's MedTech unit faces strong competition from several major players in the medical device industry like Medtronic MDT, Abbott, Stryker SYK and Boston Scientific BSX.
While Medtronic has a strong presence in cardiovascular, neuroscience and surgical technologies, Stryker Corporation is a global leader in medical technology, specializing in innovative solutions across surgical, neurotechnology, orthopedics and spine care. Boston Scientific markets products for cardiovascular, endoscopy, urology and neuromodulation. Abbott is known for its medical device products across cardiovascular, diagnostics, and diabetes care.
JNJ's Price Performance, Valuation and Estimates
J&J's shares have outperformed the industry year to date. The stock has risen 7.1% in the year-to-date period against a 0.4% decline of the industry.
From a valuation standpoint, J&J is reasonably priced. Going by the price/earnings ratio, the company's shares currently trade at 14.12 forward earnings, lower than 14.92 for the industry. The stock is also trading below its five-year mean of 15.74.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for 2025 earnings has remained unchanged at $10.60 per share over the past 60 days, while that for 2026 has declined from $11.00 to $10.98 over the same timeframe.
J&J has a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners Up
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Boston Scientific Corporation (BSX): Free Stock Analysis Report
Johnson & Johnson (JNJ): Free Stock Analysis Report
Medtronic PLC (MDT): Free Stock Analysis Report
Stryker Corporation (SYK): Free Stock Analysis Report
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
13 hours ago
- CTV News
Feds order Chinese tech firm to close Canadian operations over national security
In this Tuesday, Oct. 23, 2018, file photo, visitors pass by a booth for state-owned surveillance equipment manufacturer Hikvision at the Security China 2018 expo in Beijing, China. (AP Photo/Ng Han Guan, File) The federal government is ordering a Chinese maker of surveillance camera systems to shutter its Canadian business and leave the country over national security concerns. Industry Minister Mélanie Joly says in a post on X that the orders issues to Hikvision Canada Inc. are the result of a national security review under the Investment Canada Act. As part of the review, Joly says the government looked at information and evidence provided by Canada's security and intelligence community. She says the government ultimately determined allowing the company to keep operating in Canada would be harmful for the country's national security. On top of ordering Hikvision Canada to shut down, Joly says she is also moving to ensure the federal government, its departments, agencies and Crown corporations do not use or purchase equipment from the company. She says the government is also conducting a review of its properties to ensure legacy Hikvision products are not used going forward. She says the public should make note of these moves but stopped short of urging them to stop using Hikvision technology as well.
Globe and Mail
18 hours ago
- Globe and Mail
3 Brilliant Stocks That Could Soar by 39% to 80%, According to Wall Street
Buying and holding quality stocks is one of the most efficient ways to build wealth. Three Motley Fool contributors believe now is a great time to consider buying shares of Alibaba (NYSE: BABA), Lyft (NASDAQ: LYFT), and RH (NYSE: RH) (formerly Restoration Hardware). What's more, Wall Street analysts also see attractive upsides for these stocks based on their average price targets. Here's why these stocks are poised to soar. Alibaba stock: 39% upside John Ballard (Alibaba): Alibaba is one of the leading e-commerce and cloud service companies in the world. Intensifying competition in China's e-commerce market and regulatory uncertainty have weighed on the stock price over the past few years. But this could also spell significant upside for investors from here as the company continues to see strong demand in its cloud business. The average analyst's 12-month price target of $162 implies a 39% upside from the current share price. The stock trades at a modest forward price-to-earnings multiple of 11.7, indicating that investors are undervaluing its expected growth. Alibaba, like its U.S. counterpart Amazon, is a very tech-centered business. Investments in artificial intelligence (AI), where Alibaba Cloud offers data intelligence services and other AI services for other companies, are driving accelerating growth in its cloud business, with revenue up 18% year over year in the most recent quarter. Alibaba also uses AI in its e-commerce business to understand user behavior, make personalized product suggestions, and manage supply chains. This makes it a formidable competitor, despite its recently weak revenue growth. However, consumer spending is back on the rise in its Taobao and Tmall marketplaces. Overall, Alibaba's revenue growth has accelerated sharply in recent quarters, and it's also reporting improving margins. Analysts expect the company's earnings to grow at an annualized rate of 16% over the next several years. Given the low earnings multiple the stock trades at today, Alibaba could not only reach Wall Street's average 12-month price target but potentially double in value within the next three to five years. Lyft stock: 80% upside Jeremy Bowman (Lyft): Lyft may be a forgotten stock for most investors, and it's easy to see why. Shares of the No. 2 ridesharing company in the U.S. are down nearly 80% from where they stood at its 2019 IPO, as it entered the market overvalued and struggled during the pandemic. However, while it plays second fiddle to Ube r, Lyft has innovated with new features, recently made a smart new acquisition, and is building momentum. According to one Wall Street analyst, the stock has an 80% upside currently: Last month, Ivan Feinseth of Tigress Financial gave it a buy rating and boosted his 12-month price target on the stock by $2 to $28. Lyft is in a much stronger position than it was a couple of years ago as the company is both delivering solid growth and has turned profitable. In the first quarter, revenue rose 14% to $1.5 billion while adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) nearly doubled from $59.4 million to $106.5 million. It also posted a small profit of $2.6 million on a generally accepted accounting principles (GAAP) basis. Among the new products driving growth are price lock, which allows customers to lock in a price for a regular commute, Women+, which allows women riders and drivers to match with each other, and Lyft Silver, a service designed to fit the needs of seniors. Lyft also paved the way for its expansion into Europe by acquiring Freenow, a mobility company that's active in nine countries. Overall, Lyft looks poised to continue its double-digit percentage growth and ramp up its profitability, and the stock looks cheap at a price-to-sales ratio of around 1.1. RH stock: Up to 137% upside Jennifer Saibil (RH): RH stock has been driven down by macroeconomic pressures, but the business is bouncing back, and the stock should follow. The company is a luxury furniture retailer that operates around 100 galleries in selected affluent communities, mostly in the U.S., though it has recently been expanding into Europe. It also has robust digital channels. However, its bigger ambition is to grow itself into a diversified global luxury brand, and it already operates several upscale restaurants and experiences, including rentable jets and yachts. While its target demographics are generally more resilient than the mass market, RH hasn't been immune to inflation and economic slowdowns. But even amid sagging sales in recent years, it has continued to launch new merchandise lines and open new galleries. Its next, in Paris, is set to open shortly on the Champs-Élysées. Meanwhile, performance at its U.K. gallery has been fantastic, with sales up 47% over last year in the 2025 fiscal first quarter (which ended May 3) and online demand up 44%. Two German locations that have been open for at least a year demonstrated a 60% increase in demand in fiscal Q1, and RH is experiencing accelerating demand in its locations in Brussels and Madrid. In sum, the retailer seems to have turned a corner. It has reported year-over-year revenue increases for the past four quarters, including double-digit percentage increases for the past two quarters. The fiscal first quarter was phenomenal, with a 12% sales increase and an adjusted operating margin of 7%. Yet RH stock is 75% off its peak. The average target price on Wall Street is 24% higher than today's price, and one analyst expects it to jump 137% higher over the next 12 to 18 months. Trading at the cheap valuation of 13 times forward 1-year earnings, RH stock could be a profitable pick right now for risk-tolerant investors. Should you invest $1,000 in Alibaba Group right now? Before you buy stock in Alibaba Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Alibaba Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $704,676!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $950,198!* Now, it's worth noting Stock Advisor 's total average return is1,048% — a market-crushing outperformance compared to175%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 23, 2025 John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Jennifer Saibil has no position in any of the stocks mentioned. Jeremy Bowman has positions in Amazon and RH. John Ballard has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Amazon and Uber Technologies. The Motley Fool recommends Alibaba Group, Lyft, and RH. The Motley Fool has a disclosure policy.
Globe and Mail
a day ago
- Globe and Mail
The Stock Market Just Did Something for the Sixth Time Since 1957. History Says It Signals a Big Move in the S&P 500 in the Next Year.
Investors have experienced an exceptionally volatile market environment this year. The S&P 500 (SNPINDEX: ^GSPC) suffered its fifth-worst two-day decline in history after President Donald Trump announced his "Liberation Day" tariffs in early April, erasing $6.6 trillion in wealth. However, the benchmark index then staged one of its fastest comebacks after Trump paused the most severe tariffs for 90 days and moved to reduce the trade tensions with China that he'd previously ratcheted up. The S&P 500 rose by 6.2% in May, its best performance during that month since 1990. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » More impressive, the S&P 500 advanced 20.5% during the two-month period that ended on June 9. Since its inception in 1957, the index has only achieved a two-month return above 20% five times before. And in each of those cases, it delivered substantial additional gains in the next six months and the next year. History suggests the stock market will rocket higher in the next year The S&P 500 is considered the best barometer for the overall U.S. stock market due to its scope and diversity. The index measures the performance of 500 of the largest U.S. companies. Its components span all 11 market sectors and together account for about 80% of domestic equities by market value. The chart below shows the end dates for the five previous two-month periods when the S&P 500 gained 20% or more. It also shows how the index performed during the six-month and 12-month periods that followed them. S&P 500 Achieves 20%-Plus Return in 2 Months Forward 6-Month Return Forward 12-Month Return Feb. 6, 1975 10% 28% Oct. 6, 1982 20% 32% Dec. 7, 1998 11% 19% April 30, 2009 20% 36% May 18, 2020 21% 40% Average 16% 31% Data sources: YCharts, Carson Investment Research. In all five cases, the index kept rising. It gained an average of 16% in the next six months and 31% in the next year. On June 9, the S&P 500 closed at 6,006. If its performance from there matches the historical average: The index will advance by 16% from 6,006 to 6,967 by Dec. 9, 2025. That would be a 14% gain from its current level of 6,125. The index will advance 31% from 6,006 to 7,868 by June 9, 2026. That would be a 28% gain from its current level. Of course, the standard disclaimer applies here: Past performance is no guarantee of future results. But there is no harm in leaning into historical patterns so long as investors maintain a long-term mindset. Trump's tariffs could still derail the stock market again in the coming months The S&P 500 tumbled as much as 19% earlier this year when Trump started making radical changes to U.S. trade policy. The index has nearly recouped those losses and currently trades within a percentage point of its record high. But that does not mean tariffs will have no further impact on the stock market. The tariffs imposed to date have raised the average tax on U.S. imports to its highest level since 1941. Most economists think those duties will raise consumer prices and slow the country's economic growth. In fact, the pre-tariff consensus estimate was that U.S. gross domestic product (GDP) would increase by 2.3% this year, but the post-tariff consensus estimate is that it will increase by just 1.4%, according to Bloomberg. In early July, investors will get fresh monthly data on job openings, payrolls, unemployment, and inflation, and Trump's 90-day pause on his tariffs is due to expire on July 9. The market evidently has high expectations for the economic data considering the rebound the S&P 500 has already experienced, and Treasury Secretary Scott Bessent says Trump is likely to push back his self-imposed deadline to allow for trade negotiations to continue. However, if the economic data disappoints or Trump forges ahead with his draconian tariffs, the stock market could fall sharply. Investors need to keep that possibility in mind when they make decisions. Never buy a stock you are not prepared to hold through volatility. As Warren Buffett once advised, "You've got to be prepared when you buy a stock to have it go down 50%." Should you invest $1,000 in S&P 500 Index right now? Before you buy stock in S&P 500 Index, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and S&P 500 Index wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $704,676!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $950,198!* Now, it's worth noting Stock Advisor 's total average return is1,048% — a market-crushing outperformance compared to175%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 23, 2025
